The compound behind the GLP-1 revolution. 200+ published studies examining metabolic pathway modulation. 99%+ HPLC-verified purity. 3-lab independent COA on every batch.
GLP-1SM is a single GLP-1 (glucagon-like peptide-1) receptor agonist — the foundational compound class behind the metabolic research revolution. With over 200 published studies, it is one of the most extensively investigated peptides in glucose regulation, appetite signaling, and insulin sensitivity research.
As a GLP-1 receptor agonist, glp-1sm mimics the incretin hormone GLP-1, binding to and activating GLP-1 receptors. This mechanism has been studied for its role in metabolic pathway modulation, pancreatic beta-cell signaling, and satiety center activation in preclinical and clinical research contexts.
SMART MD also carries related next-generation compounds: GLP-2TZ (dual GIP/GLP-1 receptor agonist) and GLP-3 RT (triple GIP/GLP-1/glucagon receptor agonist) — representing the forefront of incretin research.
Extensively studied for its effects on blood glucose homeostasis through GLP-1 receptor activation. Research examines its role in glycemic control signaling, insulin secretion stimulation, and glucagon suppression in metabolic models.
Published research examines glp-1sm's interaction with hypothalamic satiety centers and its effects on food intake regulation, gastric emptying rate, and reward-pathway modulation in preclinical and clinical models.
Studies investigate glp-1sm's broader metabolic effects including lipid metabolism, cardiovascular risk marker reduction, hepatic fat reduction, and systemic inflammatory marker modulation.
Research explores glp-1sm's effects on peripheral insulin sensitivity, beta-cell preservation, and pancreatic function in models of metabolic dysfunction and insulin resistance.
GLP-1SM is a GLP-1 receptor agonist — a peptide that mimics the incretin hormone GLP-1. It is one of the most extensively studied compounds in metabolic research, with 200+ published studies examining its effects on glucose regulation, appetite signaling, and metabolic pathway modulation.
Research-grade glp-1sm with 3-lab COA verification is available at SMART MD Peptides in 10mg and 20mg formulations. Every batch is publicly verifiable at smartmdpeptides.com/verify. 99%+ HPLC purity guaranteed.
Research-grade glp-1sm is the same molecular compound verified to 99%+ purity via HPLC analysis. It is manufactured for research use only and is not FDA-approved for therapeutic administration. Pharmaceutical glp-1sm (brand names) undergoes FDA regulatory approval for specific clinical indications. The molecular structure is identical — the difference is regulatory classification and intended use.
Research-grade glp-1sm is legal to acquire for research purposes. It is classified as a research-use-only compound. Licensed researchers and physicians may acquire it for research protocols and practice-of-medicine use. SMART MD provides state-specific compliance documentation with every order.
GLP-2TZ is a dual GIP/GLP-1 receptor agonist — it activates two incretin receptors simultaneously. GLP-3 RT is a triple GIP/GLP-1/glucagon receptor agonist — the newest generation targeting three metabolic pathways. Both are available at SMART MD Peptides as related next-generation compounds building on GLP-1 research.
Check the COA before you buy. Compare it against any other supplier's documentation.